Explore the words cloud of the HeartService project. It provides you a very rough idea of what is the project "HeartService" about.
The following table provides information about the project.
GLANUM MEDICAL BV
|Coordinator Country||Netherlands [NL]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-05-01 to 2019-10-31|
Take a look of project's partnership.
|1||GLANUM MEDICAL BV||NL (EINDHOVEN)||coordinator||50˙000.00|
Cardiovascular disease (CVD) takes the lives of 17.9 million people every year, representing 31% of all global deaths. Early recognition and detection of CVDs is crucial for a patient’s chance of survival. CVD can be discovered by prolonged electrocardiogram (ECG) monitoring. Unfortunately, the chance to detect cardiac arrhythmias with the commonly used Holter systems is less than 20%. In addition, the delay between doctor visit and diagnosis is long (2 weeks), due to waiting lists in hospitals and a lack of Holter devices and resources for analysis. There is a need for cost-effective solutions for ECG monitoring to enable efficient and timely screening of patients with suspected heart problems.
Glanum Medical is a Dutch start-up company developing a small ECG monitor integrated in a patch as a ground-breaking solution that will enable early diagnoses of cardiac patients. This novel ECG patch is accurate, affordable and patient friendly as compared to conventional Holter systems. The company launches a supporting diagnostic service center for centralized diagnosis by cardiologists. Glanum Medical will provide the infrastructure for distribution and collection of the ECG patch data analysis. As such, the company empowers medical doctors to offer fast, cost-effective and high-quality ECG-based diagnosis. Glanum will introduce its ECG patch and diagnostic services in 2019 at the Dutch market as a showcase of their product. The company has the ambition to rapidly scale-up to the EU market and will use the SME Phase 1 grant to identify the optimal business strategy for exploitation of its product and service in different EU countries. The feasibility study includes analysis of EU healthcare systems, reimbursement strategies, stakeholder needs and market acceptance to facilitate large-scale roll-out from 2021.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEARTSERVICE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "HEARTSERVICE" are provided by the European Opendata Portal: CORDIS opendata.
Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any contRead More
COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLESRead More
Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.Read More